Company / Cash per Share
Fulgent Genetics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.63
FY2025
5-year range
$1.63 / $5.85
FY2021-FY2025
Trend
-12.5%
vs FY2024
Sector context
#93 of 146
Health Care
What the data says
At $1.63, Fulgent Genetics, Inc.'s cash per share ranks #93 of 146 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.36 in FY2018 to $5.85 in FY2021.
Based on SEC 10-K filings.
1.63 in FY2025 with a 5-year CAGR of -16.7%.
Declined from $2.70 to $1.63 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- -16.7%
- 10-Year CAGR
- -
Sector benchmark
#93 of 146 in Health CareTop 64% of 146This company $1.63 Sector average $27.70
▼
-94.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 12.5% year-over-year.
- Ranks #93 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.63 | -12.5% |
| FY2024 | $1.86 | -31.1% |
| FY2023 | $2.70 | +2.5% |
| FY2022 | $2.64 | -55.0% |
| FY2021 | $5.85 | +43.8% |
| FY2020 | $4.07 | +518.1% |
| FY2019 | $0.66 | +81.1% |
| FY2018 | $0.36 | -1.0% |
| FY2017 | $0.37 | -17.8% |
| FY2016 | $0.45 | +981.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026